After soaring 31%, the stock's rise on Wednesday moderated to 12%.
Wall Street wasn't particularly impressed with analysts' updates on the human capital management specialist.
The company reported promising updates for two important pipeline programs.
A financial lifeline appears to have fallen through.
Investors are excited about the potential for a settlement in opioid litigation.
Traders are feeling bullish after management provides investors with clinical and financial updates.
Alexion Pharmaceuticals will reportedly buy clinical-stage rival Achillion Pharmaceuticals in an all-cash deal.
Apple gets on board.
Data from a phase 2 study looks promising.
Shares rally after management gives investors a sneak peek at its third-quarter results.
The oil company is reportedly on the prowl.
Impressive quarterly results are lighting a fire beneath this Canadian marijuana stock.
Investors' anxiety about forthcoming earnings results appeared to weigh on the Canadian marijuana stock.
The roller-coaster ride continues.
Citi initiates coverage with a sell rating.
Merrill Lynch sees an opportunity in Yandex's sell-off.
The Chinese data center services company made two announcements.
The Permian Basin-focused oil stock is going on the offensive.
Brexit deal progress has the market excited.
One large shareholder apparently thinks it's time to buy more stock in this outdoors retailer.